NewsRx

Search our medical news database

HCV Therapies

One Year of IFN Useful in Cirrhotic Hepatitis C Patients

Published in Hepatitis Weekly, March 6th, 2000

A multicenter controlled study from Japan suggests that a 12-month course of interferon is of some use in cirrhotic patients who are infected with hepatitis C.

The selection of hepatitis C virus (HCV)-related cirrhotic patients for interferon treatment is necessary to improve the efficacy of this treatment.

"Currently, it is impossible to predict which cirrhotic patients will ultimately respond to this treatment with viral clearance," researcher A. Kasahara and colleagues from Osaka University wrote ("Pretreatment viral load and response to interferon therapy for liver cirrhosis caused by hepatitis C virus: A multicenter controlled study,"...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook